
Myant Introduces AI-Powered Cardiac Assessment Service Care360
Myant has launched Care360, an AI-driven cardiac assessment service aimed at making specialist cardiac care more accessible and preventive, announced in a press release. The service offers direct-to-patient and physician cardiac assessments, initially providing 14-day or longer evaluations delivered nationwide within 24-48 hours.
Myant Care360 is designed to transform cardiac care by integrating AI-enhanced monitoring and self-referral programs for conditions like atrial fibrillation. Patients can self-refer for screenings and receive devices at home, while physicians can refer patients online, streamlining the process. The service includes continuous ECG analysis and personalized health insights, aiming to improve early detection and management of cardiac diseases.
The initiative also features a groundbreaking Atrial Fibrillation Patient Self-Referral Program, leveraging AI-driven Holter analytics and patient-facing reports to empower patients in managing their heart health. This program is part of Myant's broader mission to make cardiac screening as routine as dental check-ups, providing comprehensive care pathways that include ongoing monitoring and virtual wellness programs.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.
Also, consider following our LinkedIn page AI Brief.
More from: Healthcare & Life Sciences
Subscribe to Daily AI Brief
Daily report covering major AI developments and industry news, with both top stories and complete market updates